NCT03635983 2025-04-01A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic MelanomaBristol-Myers SquibbPhase 3 Completed783 enrolled 24 charts
NCT04209114 2024-06-27A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder CancerBristol-Myers SquibbPhase 3 Completed114 enrolled 17 charts